Skip to Main Content

Author Details

Michael Weller
University Hospital and University of Zurich
1987
1139
137
PMIDPaper TitleJournal TitlePublished Year
36346112Association of antidepressant drug use with outcome of patients with glioblastoma.Int J Cancer2023
37488293Correcting the drug development paradigm for glioblastoma requires serial tissue sampling.Nat Med2023
37648934Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-up.J Neurooncol2023
37609137Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability.bioRxiv2023
37573572Spatial immune profiling of glioblastoma identifies an inflammatory, perivascular phenotype associated with longer survival.Acta Neuropathol2023
37641156MGMT methylation pattern of long-term and short-term survivors of glioblastoma reveals CpGs of the enhancer region to be of high prognostic value.Acta Neuropathol Commun2023
37925634Protocol for the expansion of mouse immune effector cells for in vitro and in vivo studies.STAR Protoc2023
35802605Quantitative proteomic landscapes of primary and recurrent glioblastoma reveal a protumorigeneic role for FBXO2-dependent glioma-microenvironment interactions.Neuro Oncol2023
35419607Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial.Neuro Oncol2023
37059335ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma.Radiother Oncol2023
37085569Understanding the activity of antibody-drug conjugates in primary and secondary brain tumours.Nat Rev Clin Oncol2023
37253096Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect group.Neuro Oncol2023
37343523Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas.Cell Rep Med2023
37277265Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders' Collaborative Consortium (EORTC 1419).Eur J Cancer2023
37039262Prognostic assessment in patients operated for brain metastasis from systemic tumors.Cancer Med2023
37467314Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma.Sci Transl Med2023
37335916Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma.Neuro Oncol2023
37368072A T-cell antigen atlas for meningioma: novel options for immunotherapy.Acta Neuropathol2023
37201913The anatomy of neuroepithelial tumours.Brain2023
37432631Immunotherapy for Meningiomas.Adv Exp Med Biol2023
37198490Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma.Nature2023
37030077Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer.Eur J Cancer2023
37028923Acute haemorrhagic leucoencephalitis as clinical manifestation of MOG antibody-associated disease.J Neurol Neurosurg Psychiatry2023
37224228Targeted delivery of tumor necrosis factor in combination with CCNU induces a T cell-dependent regression of glioblastoma.Sci Transl Med2023
36521332Immunotherapy for brain metastases and primary brain tumors.Eur J Cancer2023
36785654Synergies Between Venus & Exoplanetary Observations: Venus and Its Extrasolar Siblings.Space Sci Rev2023
36617262Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival.Neuro Oncol2023
36843451Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults.Neuro Oncol2023
36839699An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties.Pharmaceutics2023
36571986Differential roles of type I interferon signaling in tumor versus host cells in experimental glioma models.Transl Oncol2023
36702828Author Correction: Federated learning enables big data for rare cancer boundary detection.Nat Commun2023
36632791EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection.Neuro Oncol2023
36596831A risk model for prediction of diagnosis of cancer after ischemic stroke.Sci Rep2023
36239995A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma.Clin Cancer Res2023
36239925Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions.Neuro Oncol2023
35961053Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group.Neuro Oncol2023
35953526European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL).Neuro Oncol2023
35917833Artificial intelligence (AI)-based decision support improves reproducibility of tumor response assessment in neuro-oncology: An international multi-reader study.Neuro Oncol2023
34448057Radiotherapy for glioblastoma patients with poor performance status.J Cancer Res Clin Oncol2022
35511454Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter.Neuro Oncol2022
35380705Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors.Neuro Oncol2022
35674736Investigational PET tracers in neuro-oncology-What's on the horizon? A report of the PET/RANO group.Neuro Oncol2022
35545894Venous thromboembolic events in glioblastoma patients: An epidemiological study.Eur J Neurol2022
35404443Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period.Neuro Oncol2022
35796933Mid-term treatment-related cognitive sequelae in glioma patients.J Neurooncol2022
35608370Illuminating the Dark: Highly Selective Inhibition of Serine/Threonine Kinase 17A with Pyrazolo[1,5-<i>a</i>]pyrimidine-Based Macrocycles.J Med Chem2022
35762249Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions.Neuro Oncol2022
35534067Development of 'Core Outcome Sets' for Meningioma in Clinical Studies (The COSMIC Project): protocol for two systematic literature reviews, eDelphi surveys and online consensus meetings.BMJ Open2022
35394845A South Pole-Aitken impact origin of the lunar compositional asymmetry.Sci Adv2022
35489445Comprehensive summary and retrospective evaluation of prognostic scores for patients with newly diagnosed brain metastases treated with upfront radiosurgery in a modern patient collective.Radiother Oncol2022
  • 1 - 50 of 1,139

Recommended Authors

Massachusetts General Hospital Cancer Center, Harvard Medical School
Career Start Year 2013
Number of shared co-authors 5
Toronto Western Hospital, University Health Network, University of Toronto
Career Start Year 2010
Number of shared co-authors 32
Northwestern University
Career Start Year 2005
Number of shared co-authors 19
University of California san francisco
Career Start Year 2005
Number of shared co-authors 19
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 14
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 2002
Number of shared co-authors 14
University of California san francisco
Career Start Year 2001
Number of shared co-authors 22
Johannes Kepler University
Career Start Year 2001
Number of shared co-authors 17
Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital
Career Start Year 2001
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2000
Number of shared co-authors 9
Kumamoto University Hospital
Career Start Year 2000
Number of shared co-authors 7
Virginia Commonwealthy University
Career Start Year 1998
Number of shared co-authors 57
0The Alfred Hospital
Career Start Year 1997
Number of shared co-authors 1
Lenox Hill Hospital
Career Start Year 1997
Number of shared co-authors 5
University of Minnesota
Career Start Year 1994
Number of shared co-authors 28
Indiana University School of Medicine
Career Start Year 1994
Number of shared co-authors 20
Brain Tumor & Neuro-Oncology Cleveland Clinic Main Campus
Career Start Year 1993
Number of shared co-authors 28
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 24
Medical University of Innsbruck
Career Start Year 1990
Number of shared co-authors 18
Massachusetts General Hospital and Harvard Medical School
Career Start Year 1990
Number of shared co-authors 15
University of California san francisco
Career Start Year 1987
Number of shared co-authors 66
University of Virginia Health System
Career Start Year 1987
Number of shared co-authors 6
The Hospital for Sick Children, University of Toronto
Career Start Year 1986
Number of shared co-authors 62
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1984
Number of shared co-authors 31
Rutgers Cancer Institute of New Jersey, Rutgers University
Career Start Year 1984
Number of shared co-authors 17
Boston Children's Hospital and Harvard Medical School
Career Start Year 1982
Number of shared co-authors 50
The University of Texas MD Anderson Cancer Center
Career Start Year 1979
Number of shared co-authors 7
The University of Texas M.D. Anderson Cancer Center, American University of Beirut
Career Start Year 1979
Number of shared co-authors 20
Henry Ford Hospital
Career Start Year 1973
Number of shared co-authors 9
Heersink School of Medicine, The University of Alabama at Birmingham
Career Start Year 1970
Number of shared co-authors 41

Collaborators

Heinrich Heine University
Co-authored papers 102
Northwestern University
Co-authored papers 83
Co-authored papers 81
Medical University of Vienna
Co-authored papers 62
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Co-authored papers 54
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 41
Co-authored papers 41
Co-authored papers 40
Co-authored papers 40
Westlake University
Co-authored papers 39
Charite University Medicine Berlin
Co-authored papers 37
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 33
Moffit Cancer Center
Co-authored papers 27
Co-authored papers 23
National Cancer Institute
Co-authored papers 21
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 20
Medical University of Vienna
Co-authored papers 20
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 20
Erasmus MC Cancer Institute
Co-authored papers 19
Co-authored papers 19
Technical University
Co-authored papers 18
Princess Margaret Cancer Centre
Co-authored papers 16
Eberhard Karls University of Tuebingen
Co-authored papers 16
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 14
University of Tubingen
Co-authored papers 12
Co-authored papers 12
University Hospital Zurich
Co-authored papers 12
Co-authored papers 12
Co-authored papers 12
Co-authored papers 12